The largest trial involving DSIP to date, which included a total of 107 volunteers, reported that the peptide was generally well-tolerated with mostly minor side effects, which included [8]: Low blood pressure Increased sweating Headache Nausea Vertigo Considering that the drop in blood pressure was reported as moderate to severe in some patients, researchers should consider hypotension as a potentially exclusionary criterion for DSIP research
Discover more from The Wellness By Design Project Subscribe to get the latest posts sent to your email.
The website is user friendly
Severe atrophy with severe reduction of myocytes (black arrow) and no regeneration attempt, pronounced perimyocytic edema (postinjury day 4, c1 )
The solution should be clear
The medical record must include the date of service, testosterone cypionate dose in milligrams, injection site (typically deltoid or gluteal muscle), lot number, and NDC